Researchers at Weill Cornell Medicine have found that controlling high blood pressure may not be enough to prevent associated cognitive declines.
– Enable Injections, Inc. (“Enable”), a leader in wearable drug delivery technology, today announced an expanded partnership with Roche. – The collaboration leverages Enable’s expertise
Eli Lilly said its weight loss titan tirzepatide helped people lose up to 26% of their body weight, on average, across two late-stage clinical trials